U.S. Biotechnology Instruments Market Size Statistics Report, 2024-2033

The U.S. biotechnology instruments market size is estimated at USD 34.95 billion in 2023, and is expected to reach USD 49.11 billion by 2033, growing at a CAGR of 3.46% during the forecast period (2024-2033.

The high demand and affordability of biotechnology instrumentation. Moreover, inclination toward manual automation in biotechnology, pharmaceuticals, and related industries in this area is projected to boost the demand for advanced & sophisticated instruments to ease & accelerate process.

Furthermore, the presence of local companies and easy availability of government funding for research are anticipated to boost the market. High adoption of point-of-care diagnostic devices and continuous advancements in R&D have enhanced the capabilities of point-of-care testing systems. Moreover, novel POC devices allow real-time transmission of test results to patient's electronic medical records for easy review by physicians. The systems have also been designed to comply with changes in laboratory regulations easily.

The rising prevalence of chronic disorders, including infectious diseases, cardiovascular disorders, diabetes, cancer, and others, is expected to propel market growth. High unmet medical needs for cardiovascular diseases and increasing patient awareness are expected to boost the demand for IVD instruments. An increase in the adoption of unhealthy habits, such as smoking, a rise in the incidence of obesity, and dietary irregularities are responsible for the increase in prevalence of cardiovascular diseases. Moreover, the prevalence of diabetes is increasing, widening the patient pool.

The U.S. biotechnology instruments market accounted for 40% of the global biotechnology instruments market in 2023. This can be attributed mainly to the growing demand for automation in industrial and clinical settings. Automation in the industrial workplace has enabled companies to maximize output and profits, whereas laboratory automation in clinical settings has increased speed & reliability of patient data. A report stated that biotech startups offer on-demand experimental automation and outsourcing scientific research & development services. Such initiatives have improved the accessibility of automation services at the industrial level, boosting the market.

Get Sample Copy of Report@ https://www.novaoneadvisor.com/report/sample/8488

U.S. Biotechnology Instruments Market Key Takeaways

• Based on product, analytical instruments accounted for the largest market share of 65.9% in 2023.
• The cell culture instruments segment is expected to grow at the fastest CAGR during the forecast period.
• Based on end use, pharmaceutical & biotechnology companies dominated the biotechnology instruments market with a market share of 40.11% in 2023.
• The academic & research industries segment is expected to grow at the fastest CAGR of 5.08% from 2024 to 2033.

Immediate Delivery Available, Get Full Access@

https://www.novaoneadvisor.com/report/checkout/8488

U.S. Biotechnology Instruments Market Recent Developments

• In February 2024, SkyWater Technology announced its production agreement with Nautilus Biotechnology, Inc., intending to supply silicon-based microfluidic biochips for proteome analysis system by Nautilus’
• In February 2024, BioDot, Inc., announced the launch of MODULIS which is a combination of the BioJet and SuperTrak Gen3 smart conveyance and ATS Smart vision platforms
• In October 2023, Roche announced the U.S. launch of cobas connection modules (CCM) Vertical which is the only laboratory conveyor system in the U.S. that is capable of moving samples vertically without reducing overall track speed, throughput, or turnaround times.

Key U.S. Biotechnology Instruments Company Insights

Some prominent U.S. biotechnology instruments market companies include Thermo Fisher Scientific, Inc.; F. Hoffmann-La Roche Ltd.; Agilent Technologies; Bio-Rad Laboratories, Inc.; Illumina, Inc.; Waters Corp.; Danaher; Avantor, Inc.; and Shimadzu Corp. Companies are engaged in continuous development of advanced tools for life sciences research.

Biotechnology instruments have gained significant attention in recent years. This can be attributed to the expanding pool of companies coupled with the need to incorporate advanced instrumentation across different workflows in the biotechnology industry.

U.S. Biotechnology Instruments Market Top Key Companies:

• Thermo Fisher Scientific, Inc.
• Waters Corp.
• Shimadzu Corp.
• Danaher
• Agilent Technologies, Inc.
• Bruker Corp.
• PerkinElmer, Inc.
• Mettler Toledo
• Zeiss Group
• Bio-Rad Laboratories, Inc.
• Illumina, Inc.
• Eppendorf SE
• F. Hoffmann-La Roche AG
• Sartorius AG
• Avantor, Inc.

U.S. Biotechnology Instruments Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the U.S. Biotechnology Instruments market.

By Product?

• Analytical Instruments Polymerase Chain Reaction Spectroscopy Microscopy Chromatography Flow Cytometry Sequencing Microarray Others
• Cell Culture Instruments Culture Systems Incubators Cryostorage Equipment Biosafety Equipment Pipetting Instruments
• Cell Separation Instruments Centrifuge Filtration Systems Magnetic-activated Cell Separator Systems
• Immunoassay Instruments
• Clinical Chemistry Analyzers
• Others

By End-use?

• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Laboratories
• Academic & Research Institutes
• Others

Immediate Delivery Available | Buy This Premium Research

https://www.novaoneadvisor.com/report/checkout/8488

Frequently Asked Questions

1. What geographic regions does your market research cover for the U.S. Biotechnology Instruments market?

?? We have a global reach, with expertise spanning across continents, including North America, Europe, Asia-Pacific, Latin America, and the Middle East. We leverage a combination of primary and secondary research methodologies to offer country-level analysis.

1. How does your firm conduct cross-sectional analysis for the U.S. Biotechnology Instruments market?

?? We conduct cross-sectional analysis by examining data from different individuals at a single point in time to identify patterns and trends across diverse segments of the market.

1. Can your firm customize market research solutions to meet specific client needs?

?? Our experienced team works closely with clients to gain a thorough understanding of their business goals and target markets. We have the expertise and flexibility to develop bespoke research solutions.

1. Do you offer ongoing support or consultation to clients after the completion of a market research project?

?? Our team of experienced analysts is available to address any questions, concerns and needs that may arise following the delivery of the report.

1. Can your market research firm help with competitor analysis for U.S. Biotechnology Instruments market?

?? Through a combination of quantitative and qualitative research methodologies, we meticulously assess the strengths, weaknesses, strategies, and market positioning of your competitors.

Order the 150+ Pages Detailed Report @ https://www.novaoneadvisor.com/report/checkout/8488

Call: USA: +1 650 460 3308 | IND: +91 87933 22019 |Europe: +44 2080772818

Email: [email protected]

Web: https://www.novaoneadvisor.com/